title: Wnt/ß-catenin: a new therapeutic approach to acute myeloid leukemia.
abstract: Recent studies have shown genetic and epigenetic aberrations resulting in aberrant activation of the Wingless-Int (Wnt) pathway, thus influencing the initiation and progression of acute myeloid leukemia (AML). Of major importance, these findings may lead to novel treatment strategies exploiting targeted modulation of Wnt signaling. This paper comprises the latest status of knowledge concerning the role of Wnt pathway alteration in AML and outlines future lines of research and their clinical perspectives.
authors.affiliation: Department of Internal Medicine III, Center for Integrated Oncology (CIO), University of Bonn, Sigmund-Freud-Straße 25, 53105 Bonn, Germany.
authors.forename: Y
authors.initials: Y
authors.lastname: Kim
authors.forename: S
authors.initials: S
authors.lastname: Thanendrarajan
authors.forename: I G H
authors.initials: IG
authors.lastname: Schmidt-Wolf